GGrantIndex
← Leaderboards

Ningjun Li

Virginia Commonwealth University

$8,697,975
Attributed
$8,697,975
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $739.9K · FY200725
$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,697,975 · 7

By mechanism

R01$8,072,784 · 5
R21$625,191 · 2

Top collaborators

No co-investigators on record.

Most similar at Virginia Commonwealth University

Same institution · by research overlap

Others in their field

Top investigators on “Kidney

Research focus

KidneyMolecularHypertensionRegulationMediatingPathogenesisSodiumInsightExcretory FunctionTubular FormationSalt IntakeBaseBlood PressureKidney MedullaFunctional DisorderEnzymesAttenuatedImpairmentProductionRattusSalt SensitiveResponseSodium ChlorideCells

Grant awards (26)

Renal acid ceramidase-S1P pathway in salt-sensitive hypertension$467,473
R01 · FY2025 · DK · contact PI
Inhibition of diacylglycerol lipase α as a novel strategy to mitigate the nephrotoxicity of cisplatin$227,221
R21 · FY2025 · CA · contact PI
Renal acid ceramidase-S1P pathway in salt-sensitive hypertension$467,473
R01 · FY2024 · DK · contact PI
Inhibition of fatty acid amide hydrolase as a novel strategy to prevent nephrotoxicity of cisplatin.$174,276
R21 · FY2023 · CA · contact PI
Renal sphingosine-1-phosphate receptor 1 in salt-sensitive hypertension$387,080
R01 · FY2022 · HL · contact PI
Inhibition of fatty acid amide hydrolase as a novel strategy to prevent nephrotoxicity of cisplatin.$223,694
R21 · FY2022 · CA · contact PI
Renal sphingosine-1-phosphate receptor 1 in salt-sensitive hypertension$400,830
R01 · FY2021 · HL · contact PI
Renal sphingosine-1-phosphate receptor 1 in salt-sensitive hypertension$387,500
R01 · FY2020 · HL · contact PI
Renal sphingosine-1-phosphate receptor 1 in salt-sensitive hypertension$387,500
R01 · FY2019 · HL · contact PI
Molecular mechanism of hypertension-induced renal injury: the role of HIF-1alpha$232,875
R01 · FY2019 · DK · contact PI
Molecular mechanism of hypertension-induced renal injury: the role of HIF-1alpha$232,500
R01 · FY2018 · DK · contact PI
Molecular mechanism of hypertension-induced renal injury: the role of HIF-1alpha$232,500
R01 · FY2017 · DK · contact PI
Renal Medullary HIF Prolyl Hydroxylases and Salt Sensitivity of Blood Pressure$381,250
R01 · FY2016 · HL · contact PI
Renal Medullary HIF Prolyl Hydroxylases and Salt Sensitivity of Blood Pressure$375,531
R01 · FY2015 · HL · contact PI
Renal Medullary HIF Prolyl Hydroxylases and Salt Sensitivity of Blood Pressure$373,625
R01 · FY2014 · HL · contact PI
Renal Medullary Stem Cell Niche in Salt Sensitive Hypertension$366,275
R01 · FY2014 · HL · contact PI
Renal Medullary HIF Prolyl Hydroxylases and Salt Sensitivity of Blood Pressure$362,950
R01 · FY2013 · HL · contact PI
Renal Medullary Stem Cell Niche in Salt Sensitive Hypertension$355,810
R01 · FY2013 · HL · contact PI
Renal Medullary Stem Cell Niche in Salt Sensitive Hypertension$373,750
R01 · FY2012 · HL · contact PI
Renal Medullary Stem Cell Niche in Salt Sensitive Hypertension$373,750
R01 · FY2011 · HL · contact PI
Renal medullary HIF prolyl hydroxylases and salt sensitivity of blood pressure$335,250
R01 · FY2011 · HL · contact PI
Renal medullary HIF prolyl hydroxylases and salt sensitivity of blood pressure$335,250
R01 · FY2010 · HL · contact PI
Renal medullary HIF prolyl hydroxylases and salt sensitivity of blood pressure$335,250
R01 · FY2009 · HL · contact PI
Renal medullary HIF prolyl hydroxylases and salt sensitivity of blood pressure$237,862
R01 · FY2009 · HL · contact PI
Renal medullary HIF prolyl hydroxylases and salt sensitivity of blood pressure$335,250
R01 · FY2008 · HL · contact PI
Renal medullary HIF prolyl hydroxylases and salt sensitivity of blood pressure$335,250
R01 · FY2007 · HL · contact PI